Fig. 12

Pathway analysis highlighting downregulation of fatty acid biosynthesis in response to IMOs treatment, a favorable shift for diabetes and hyperlipidemia
Pathway analysis highlighting downregulation of fatty acid biosynthesis in response to IMOs treatment, a favorable shift for diabetes and hyperlipidemia